(Q38000939)

26 August 2017

title

Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells (English)

1 reference

26 August 2017

1 reference

Chunhui Xu

1

1 reference

26 August 2017

publication date

30 March 2012

1 reference

Journal of Molecular and Cellular Cardiology

26 August 2017

published in

1 reference

26 August 2017

volume

52

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

1203-1212

1 reference

iPS cells: a source of cardiac regeneration

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Modelling the long QT syndrome with induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Patient-specific induced pluripotent stem-cell models for long-QT syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Present state and future perspectives of using pluripotent stem cells in toxicology research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Embryonic stem cell lines derived from human blastocysts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Functional cardiomyocytes derived from human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Cardiomyocyte differentiation of human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Cardiac muscle regeneration: lessons from development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Geometric control of cardiomyogenic induction in human pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Mass preparation of size-controlled mouse embryonic stem cell aggregates and induction of cardiac differentiation by cell patterning method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

3-D microwell culture of human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Regulation of avian cardiac myogenesis by activin/TGFbeta and bone morphogenetic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

A role for bone morphogenetic proteins in the induction of cardiac myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Activin-A and FGF-2 mimic the inductive effects of anterior endoderm on terminal cardiac myogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Inhibition of Wnt activity induces heart formation from posterior mesoderm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Wnt antagonism initiates cardiogenesis in Xenopus laevis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Marked differences in differentiation propensity among human embryonic stem cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Derivation of human induced pluripotent stem cells for cardiovascular disease modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

BMP2 is required for early heart development during a distinct time period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Cardiac commitment of primate embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Inhibition of precardiac mesoderm cell proliferation by antisense oligodeoxynucleotide complementary to fibroblast growth factor-2 (FGF-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

5-azacytidine induces cardiac differentiation of P19 embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Induced muscle differentiation in an embryonal carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Identification and selection of cardiomyocytes during human embryonic stem cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Highly enriched cardiomyocytes from human embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Transgenic enrichment of cardiomyocytes from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Formation of human myocardium in the rat heart from human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Nongenetic method for purifying stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Human embryonic and induced pluripotent stem cells in basic and clinical research in cardiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Cardiogenic differentiation and transdifferentiation of progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Calcium handling in human embryonic stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Electromechanical integration of cardiomyocytes derived from human embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Imaging: guiding the clinical translation of cardiac stem cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Stem-cell therapy for cardiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Protocols for cardiac differentiation of embryonic stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

Human embryonic stem cell-derived cardiomyocytes can be maintained in defined medium without serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.03.012

10.1016/J.YJMCC.2012.03.012

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference